Merck & Co., Inc. (MRK) Insider Trading & Ownership $89.40 +1.72 (+1.96%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$89.30 -0.09 (-0.10%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Merck & Co., Inc. (NYSE:MRK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.09%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$250,012.25Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$209,562.36 Get MRK Insider Trade Alerts Want to know when executives and insiders are buying or selling Merck & Co., Inc. stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRK Insider Buying and Selling by Quarter Merck & Co., Inc. Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/6/2025Cristal N DowningInsiderSell2,361$88.76$209,562.36 2/6/2025Inge G ThulinDirectorBuy2,833$88.25$250,012.25 (Data available from 1/1/2013 forward) MRK Insider Trading Activity - Frequently Asked Questions Who is on Merck & Co., Inc.'s Insider Roster? The list of insiders at Merck & Co., Inc. includes Cristal N Downing, Inge G Thulin, Johannes Jacobus Oosthuizen, Joseph Romanelli, Kenneth C Frazier, Richard R Deluca, Rita A Karachun, Robert M Davis, Sanat Chattopadhyay, and Steven Mizell. Learn more on insiders at MRK. What percentage of Merck & Co., Inc. stock is owned by insiders? 0.09% of Merck & Co., Inc. stock is owned by insiders. Learn more on MRK's insider holdings. Which Merck & Co., Inc. insiders have been buying company stock? The following insiders have purchased MRK shares in the last 24 months: Inge G Thulin ($250,012.25), and Joseph Romanelli ($14,684.96). How much insider buying is happening at Merck & Co., Inc.? Insiders have purchased a total of 2,972 MRK shares in the last 24 months for a total of $264,697.21 bought. Which Merck & Co., Inc. insiders have been selling company stock? The following insiders have sold MRK shares in the last 24 months: Cristal N Downing ($209,562.36), Johannes Jacobus Oosthuizen ($213,052.78), Joseph Romanelli ($128,552.75), Richard R Deluca ($20,964,313.77), Rita A Karachun ($1,865,788.75), Robert M Davis ($16,472,801.97), Sanat Chattopadhyay ($15,425,708.85), and Steven Mizell ($13,713,526.60). How much insider selling is happening at Merck & Co., Inc.? Insiders have sold a total of 597,002 Merck & Co., Inc. shares in the last 24 months for a total of $68,993,307.83 sold. Which members of congress are trading Merck & Co., Inc.? Julie Johnson (D-TX), Jared Moskowitz (D-FL), C. Scott Franklin (R-FL), and Kathy E. Manning (D-NC) have bought shares of Merck & Co., Inc. in the last year totaling $32,000. Josh Gottheimer (D-NJ), Gilbert Ray Cisneros, Jr. (D-CA), Byron Donalds (R-FL), Jared Moskowitz (D-FL), Jonathan L. Jackson (D-IL), John James (R-MI), and Michael C. Burgess (R-TX) have sold shares totaling $113,000. Merck & Co., Inc. Key ExecutivesMr. Robert M. Davis J.D. (Age 57)Chairman, President & CEO Compensation: $5.57MMs. Caroline Litchfield (Age 55)Executive VP & CFO Compensation: $3.09MMr. Richard R. DeLuca Jr. (Age 61)Executive VP & President of Merck Animal Health Compensation: $2.4MMr. Sanat Chattopadhyay (Age 64)Executive VP & President of Merck Manufacturing Division Compensation: $2.49MDr. Dean Y. Li M.D. (Age 61)Ph.D., Executive VP & President of Merck Research Laboratories Compensation: $3.61MMr. Dalton E. Smart III (Age 57)Senior VP of Finance, Principal Accounting Officer & Global Controller Mr. David Michael Williams (Age 55)Executive VP and Chief Information & Digital Officer Mr. Peter DannenbaumVice President of Investor RelationsMs. Jennifer L. Zachary (Age 46)Executive VP & General Counsel Compensation: $2.73MLisa LeCointe-Cephas (Age 42)Senior VP and Chief Ethics & Compliance Officer More Insider Trading Tools from MarketBeat Related Companies Eli Lilly and Company Insider Selling Johnson & Johnson Insider Selling AbbVie Insider Selling Pfizer Insider Selling Bristol-Myers Squibb Insider Selling Zoetis Insider Selling Royalty Pharma Insider Selling Jazz Pharmaceuticals Insider Selling Corcept Therapeutics Insider Selling Perrigo Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NYSE:MRK) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck & Co., Inc. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
